Research and Markets: Future Trends in Treatment of Prostate Cancer and Management of Disease and Treatment Side Effects Revealed.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c12474) has announced the addition of Stakeholder Insight: Prostate Cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. Treatment in the USA to their offering. Prostate cancer is the most common male malignancy in Western countries. Increasing usage of screening and changes in treatment practice means companies will have to adapt to exploit the market. This Insight details physician opinion of currently available products and disease management practice and what they require in the future. AstraZeneca is promoting Casodex monotherapy heavily in non-metastatic disease as an alternative to an LHRH LHRH abbr. luteinizing hormone-releasing hormone LHRH Luteinizing hormone-releasing hormone, GnRH, gonadotropin-releasing hormone, LRH, LRF Endocrinology A decapeptide synthesized by hypothalamic neurons which agonist agonist /ag·o·nist/ (ag´ah-nist) 1. one involved in a struggle or competition. 2. agonistic muscle. 3. . Approval for Casodex monotherapy has been delayed in some markets, but physicians are already prescribing off-label, especially in patients with dementia, a condition that can be exacerbated by the use of LHRH agonists.Clinical trials have shown the lack of activity of estramustine in hormone refractory prostate cancer, but the drug is still commonly used because of the lack of alternatives. Recent trial results of estramustine in combination with Aventis Taxotere show much greater efficacy and usage of this combination is already significant. Information provided Includes: --Quantitative treatment data from 80 physicians from the US --Qualitative feedback on key findings and future trends in the treatment of prostate cancer and the management of disease and treatment side effects Side effects Effects of a proposed project on other parts of the firm. --Coverage of the hot topics affecting current treatment patterns, from the impact of IMRT IMRT Intensity-modulated radiation therapy Radiation oncology A format for delivering high-dose RT to regions–eg, nasopharynx, that are surrounded by radiation-sensitive areas; in IMRT, a broad radiation field is divided into hundreds of small pencil beams, on brachytherapy to the increasing use of bisphosphonates --A strong future focus on key issues, including the increasing use of third generation cytotoxics in HRPC HRPC Hormone-Refractory Prostate Cancer HRPC Hormone-Resistant Prostate Cancer HRPC Hudson River Parks Conservancy HRPC Health Research and Policy Center This information will enable readers: --Identify hot topics and key issues for practicing prostate cancer specialists the questions they really want answered --Predict future trends in the treatment of prostate cancer and how to capitalize on Cap´i`tal`ize on` v. t. 1. To turn (an opportunity) to one's advantage; to take advantage of (a situation); to profit from; as, to capitalize on an opponent's mistakes s>. forthcoming changes in treatment practice --Plan product development to fill prostate cancer market niches as defined by practicing physicians For more information visit http://www.researchandmarkets.com/reports/c12474 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion